Who Supplies Escitalopram? Top Manufacturers & Their Global Buyers
India accounts for a significant share of global Escitalopram exports, with 231+ registered manufacturers shipping to buyers across 95+ countries — yet a handful of companies dominate the shipments. MEDISPRAY LABORATORIES PRIVATE LIMITED holds the largest share at 39.3% (export value: $77.3M). Close behind, TORRENT PHARMACEUTICALS LTD (5.8%, $11.5M). AUROBINDO PHARMA LTD (4.8%, $9.5M). The Sankey diagram below maps every supplier's customer flow in detail. All figures are drawn from Indian Customs (DGFT) shipping bill records.
🏭 Market Analysis: Top Suppliers & Customer Networks
Comprehensive supplier network intelligence dashboard
Who Supplies Escitalopram? Top Manufacturers & Their Buyers
Flow of Escitalopram from leading Indian exporters to their key global customers
Supplier-Customer Network Analysis
Top Suppliers → Customer Networks
Escitalopram Supplier Network — Key Market Intelligence
The Escitalopram export market from India is led by MEDISPRAY LABORATORIES PRIVATE LIMITED, which alone commands a 39.3% share, shipping $77.3M worth of product across 77 shipments. The second-largest exporter, TORRENT PHARMACEUTICALS LTD, contributes $11.5M (5.8%) to the overall market. Combined, the top two suppliers alone account for 45.1% of all Escitalopram exports, indicating a relatively concentrated supply base.
Across all 231 tracked manufacturers, the total Escitalopram export value stands at $196.7M from 5.5K shipments. The market average shipment value is $36.1K. The single largest buyer relationship in terms of trade value is CIPLA MAROC, receiving $77.0M worth of product.
The combined buyer network spans 16 named purchasing companies, including CIPLA MAROC, CIPLA MAROC ANGLE RU, TORRENT PHARMA INC, TORRENT PHARMA INC IMPORTER EIN 36-4547412, HEUMANN PHARMA GMBH and 11 others. These buyers represent pharmaceutical manufacturers, distributors, hospital procurement groups, and generic drug producers operating across multiple continents.
Market Analysis: Top Suppliers & Their Customer Networks
1MEDISPRAY LABORATORIES PRIVATE LIMITED
MEDISPRAY LABORATORIES PRIVATE LIMITED is the first-largest Escitalopram exporter from India, with a market share of 39.3% and a total export value of $77.3M across 77 shipments. Their average shipment value of $1.0M is above the market average of $36.1K, suggesting premium or bulk contract pricing.
MEDISPRAY LABORATORIES PRIVATE LIMITED serves 3 named buyers in our database. CIPLA MAROC is the dominant customer, accounting for 99.5% of this supplier's tracked business. Top customers include:
• CIPLA MAROC — $77.0M across 77 shipments (99.5% of this supplier's total exports)
• CIPLA MAROC ANGLE RU — $214.9K across 0 shipments (0.3% of this supplier's total exports)
• CIPLA MAROC — $135.2K across 0 shipments (0.2% of this supplier's total exports)
Key Insight: MEDISPRAY LABORATORIES PRIVATE LIMITED's per-shipment value of $1.0M is 2686% above the market average of $36.1K, consistent with large-order contracts or value-added formulations.
2TORRENT PHARMACEUTICALS LTD
TORRENT PHARMACEUTICALS LTD is the second-largest Escitalopram exporter from India, with a market share of 5.8% and a total export value of $11.5M across 242 shipments. Their average shipment value of $47.4K is above the market average of $36.1K, suggesting premium or bulk contract pricing.
TORRENT PHARMACEUTICALS LTD serves 5 named buyers in our database. TORRENT PHARMA INC is the dominant customer, accounting for 72.3% of this supplier's tracked business. Top customers include:
• TORRENT PHARMA INC — $8.3M across 175 shipments (72.3% of this supplier's total exports)
• TORRENT PHARMA INC IMPORTER EIN 36-4547412 — $1.4M across 30 shipments (12.4% of this supplier's total exports)
• HEUMANN PHARMA GMBH — $806.5K across 17 shipments (7.0% of this supplier's total exports)
• DKSH MALAYSIA SDN BH — $526.1K across 11 shipments (4.6% of this supplier's total exports)
• HEUMANN PHARMA GMBH — $422.6K across 9 shipments (3.7% of this supplier's total exports)
Key Insight: TORRENT PHARMACEUTICALS LTD's per-shipment value of $47.4K is 32% above the market average of $36.1K, consistent with large-order contracts or value-added formulations.
3AUROBINDO PHARMA LTD
AUROBINDO PHARMA LTD is the third-largest Escitalopram exporter from India, with a market share of 4.8% and a total export value of $9.5M across 605 shipments. Their average shipment value of $15.6K is below the market average of $36.1K, reflecting a high-volume, competitive pricing strategy.
AUROBINDO PHARMA LTD serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• AUROLOGISTICS LLC AUROBINDO PHARM — $4.3M across 278 shipments (46.0% of this supplier's total exports)
• AUROLOGISTICS LLC AUROBINDO PHARM — $1.9M across 122 shipments (20.1% of this supplier's total exports)
• AUROLOGISTICS LLC — $1.1M across 71 shipments (11.7% of this supplier's total exports)
• AURO PHARMA INC, — $1.1M across 69 shipments (11.5% of this supplier's total exports)
• APL SWIFT SERVICES ( — $1.0M across 65 shipments (10.7% of this supplier's total exports)
Key Insight: AUROBINDO PHARMA LTD operates with high shipment frequency (605 shipments) at a per-shipment value of $15.6K, indicating a broad distribution network with many smaller, regular orders.
4AUROBINDO PHARMA LIMITED
AUROBINDO PHARMA LIMITED is the fourth-largest Escitalopram exporter from India, with a market share of 3.7% and a total export value of $7.3M across 218 shipments. Their average shipment value of $33.5K is below the market average of $36.1K, reflecting a high-volume, competitive pricing strategy.
AUROBINDO PHARMA LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• AUROLOGISTICS LLC AUROBINDO PHARM — $3.5M across 104 shipments (47.6% of this supplier's total exports)
• AUROLOGISTICS LLC — $1.8M across 53 shipments (24.4% of this supplier's total exports)
• AUROLOGISTICS LLC AUROBINDO PHARM — $717.3K across 21 shipments (9.8% of this supplier's total exports)
• AUROLOGISTICS LLC AUROBINDO PHARM — $669.1K across 20 shipments (9.2% of this supplier's total exports)
• AUROLOGISTICS LLC AUROBINDO PHARM — $653.1K across 20 shipments (8.9% of this supplier's total exports)
Key Insight: AUROBINDO PHARMA LIMITED operates with high shipment frequency (218 shipments) at a per-shipment value of $33.5K, indicating a broad distribution network with many smaller, regular orders.
5SANDOZ PRIVATE LIMITED
SANDOZ PRIVATE LIMITED is the fifth-largest Escitalopram exporter from India, with a market share of 3.4% and a total export value of $6.7M across 281 shipments. Their average shipment value of $23.8K is below the market average of $36.1K, reflecting a high-volume, competitive pricing strategy.
SANDOZ PRIVATE LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• LEK S.A. — $2.8M across 117 shipments (41.5% of this supplier's total exports)
• LEK S.A. — $2.1M across 87 shipments (30.9% of this supplier's total exports)
• SANDOZ DO BRASIL IND FARMACEUTICA — $904.8K across 38 shipments (13.5% of this supplier's total exports)
• SAMIL PHARMACEUTICAL — $579.1K across 24 shipments (8.7% of this supplier's total exports)
• SANDOZ DO BRASIL IND FARMACEUTICA — $361.6K across 15 shipments (5.4% of this supplier's total exports)
Key Insight: SANDOZ PRIVATE LIMITED operates with high shipment frequency (281 shipments) at a per-shipment value of $23.8K, indicating a broad distribution network with many smaller, regular orders.
6SUN PHARMACEUTICAL INDUSTRIES LIMITED
SUN PHARMACEUTICAL INDUSTRIES LIMITED is the fifth-largest Escitalopram exporter from India, with a market share of 2.0% and a total export value of $3.9M across 293 shipments. Their average shipment value of $13.3K is below the market average of $36.1K, reflecting a high-volume, competitive pricing strategy.
SUN PHARMACEUTICAL INDUSTRIES LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• YUSEN LOGISTICS BENELUX BELGIUM — $1.4M across 106 shipments (36.0% of this supplier's total exports)
• RANBAXY (THAILAND) C — $855.6K across 64 shipments (22.0% of this supplier's total exports)
• M S SUN PHARMACEUTIC — $770.0K across 58 shipments (19.8% of this supplier's total exports)
• YUSEN LOGISTICS BENELUX BELGIUM — $518.7K across 39 shipments (13.3% of this supplier's total exports)
• M S SUN PHARMACEUTIC — $349.3K across 26 shipments (9.0% of this supplier's total exports)
Key Insight: SUN PHARMACEUTICAL INDUSTRIES LIMITED operates with high shipment frequency (293 shipments) at a per-shipment value of $13.3K, indicating a broad distribution network with many smaller, regular orders.
From Indian Factories to Global Pharmacies — How Escitalopram Flows
Once Escitalopram leaves the manufacturing plants of companies like MEDISPRAY LABORATORIES PRIVATE LIMITED and TORRENT PHARMACEUTICALS LTD, it travels to 5 destination markets with a combined import value of $196.7M. Morocco absorbs the largest share at 40.9% ($80.4M), followed by United States (23.6%) and Australia (4.2%).
In Morocco — the top destination — named importers include CIPLA MAROC. In United States, key buyers are TORRENT PHARMA INC, AUROLOGISTICS LLC (AUROBINDO PHARMA, AUROLOGISTICS LLC AUROBINDO PHARM.
This geographic spread reflects Escitalopram's role as an essential active pharmaceutical ingredient (API) and finished dosage form — sourced primarily from India due to its cost-competitive, WHO-compliant manufacturing base. The Sankey diagram below maps these destination countries to their named importers in detail.
🌍 Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Where Does Escitalopram Go? Top Importing Countries & Their Buyers
Trade flow of Escitalopram exports from India — top destination countries and the named companies importing it
Geographic Market Flow Analysis
Top Countries → Global Importers
Market Analysis: Top Importing Countries & Their Importers
1Morocco
Morocco ranks as the first-largest destination for Escitalopram imports from India, with a total trade value of $80.4M across 71 shipments — representing a 40.9% share of all Escitalopram exports. The average shipment value of $1.1M is above the global average of $36.1K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Escitalopram importers in Morocco: CIPLA MAROC is the largest buyer, accounting for 96.0% ($77.2M) of this market's total imports.
• CIPLA MAROC — $77.2M (96.0% of Morocco's total)
Key Insight: Morocco's per-shipment average of $1.1M (3041% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Morocco is a key market for Escitalopram imports from India.
2United States
United States ranks as the second-largest destination for Escitalopram imports from India, with a total trade value of $46.5M across 514 shipments — representing a 23.6% share of all Escitalopram exports. The average shipment value of $90.4K is above the global average of $36.1K, indicating high-value procurement contracts or branded formulations. This market is served by 9 tracked buyers.
Named Escitalopram importers in United States: TORRENT PHARMA INC is the largest buyer, accounting for 23.0% ($10.7M) of this market's total imports.
• TORRENT PHARMA INC — $10.7M (23.0% of United States's total)
• AUROLOGISTICS LLC (AUROBINDO PHARMA — $4.8M (10.4% of United States's total)
• AUROLOGISTICS LLC AUROBINDO PHARM — $3.5M (7.5% of United States's total)
Key Insight: United States's per-shipment average of $90.4K (151% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
United States is a key market for Escitalopram imports from India.
3Australia
Australia ranks as the third-largest destination for Escitalopram imports from India, with a total trade value of $8.3M across 27 shipments — representing a 4.2% share of all Escitalopram exports. The average shipment value of $307.6K is above the global average of $36.1K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Escitalopram importers in Australia: SANDOZ PTY LTD, is the largest buyer, accounting for 20.8% ($1.7M) of this market's total imports.
• SANDOZ PTY LTD, — $1.7M (20.8% of Australia's total)
Key Insight: Australia's per-shipment average of $307.6K (753% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Australia is a key market for Escitalopram imports from India.
4Canada
Canada ranks as the fourth-largest destination for Escitalopram imports from India, with a total trade value of $7.7M across 61 shipments — representing a 3.9% share of all Escitalopram exports. The average shipment value of $126.9K is above the global average of $36.1K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.
Named Escitalopram importers in Canada: AURO PHARMA INC, is the largest buyer, accounting for 19.4% ($1.5M) of this market's total imports.
• AURO PHARMA INC, — $1.5M (19.4% of Canada's total)
• APOTEX INC, — $1.3M (17.4% of Canada's total)
Key Insight: Canada's per-shipment average of $126.9K (252% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Canada is a key market for Escitalopram imports from India.
5Poland
Poland ranks as the fifth-largest destination for Escitalopram imports from India, with a total trade value of $6.9M across 143 shipments — representing a 3.5% share of all Escitalopram exports. The average shipment value of $48.4K is above the global average of $36.1K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.
Named Escitalopram importers in Poland: LEK S.A. is the largest buyer, accounting for 59.2% ($4.1M) of this market's total imports.
• LEK S.A. — $4.1M (59.2% of Poland's total)
• LEK S A — $2.1M (29.9% of Poland's total)
Key Insight: Poland's per-shipment average of $48.4K (34% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Poland is a key market for Escitalopram imports from India.
People Also Ask — Escitalopram Supplier & Trade Network
Who are the top suppliers of Escitalopram from India?+
Which companies buy Escitalopram from Indian manufacturers?+
Where does Escitalopram exported from India go?+
What is the market share of the top Escitalopram supplier from India?+
What is the average shipment value for Escitalopram exports from India?+
Is Escitalopram manufactured in India and exported globally?+
Which country imports the most Escitalopram from India?+
Who are the buyers of Escitalopram in United States?+
How concentrated is the Escitalopram supplier market in India?+
How do I find verified buyers for Escitalopram in specific countries?+
Escitalopram Trade Network — Key Takeaways
- 1MEDISPRAY LABORATORIES PRIVATE LIMITED is India's dominant Escitalopram exporter with a 39.3% market share and $77.3M in total exports — making it the single most important sourcing entity in this market.
- 2The top 231 suppliers collectively account for 59.0% of all tracked Escitalopram exports, with a combined trade value of $196.7M.
- 3Morocco is the largest destination market, absorbing 40.9% of India's Escitalopram exports ($80.4M). United States (23.6%) and Australia (4.2%) follow.
- 4With 5.5K total shipments averaging $36.1K each, the Escitalopram export trade from India reflects both bulk API supply and finished dosage form distribution.
- 5Verified buyers across the network include CIPLA MAROC, CIPLA MAROC ANGLE RU, TORRENT PHARMA INC, TORRENT PHARMA INC IMPORTER EIN 36-4547412 — representing a diverse base of pharmaceutical importers, distributors, and generic drug manufacturers globally.
Network Overview
Supplier Network
Country Network
Network Insights
Top supplier: 3 customers
6 suppliers → 95 countries
Network value: $196.7M
Related Analysis
Market Intelligence
Latest developments and market context
Detailed market intelligence for Escitalopram — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Escitalopram.
- 2.Flow Mapping: 231 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
- 3.Value Aggregation: Trade value per supplier-buyer link aggregated from 5,457 individual shipment records. Values are FOB in USD.
- 4.Geographic Clustering: Buyer networks clustered across 95 destination countries to identify geographic concentration patterns.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
5,457 Verified Shipments
231 manufacturers in network
Expert-Reviewed
By pharmaceutical trade specialists